Evidence map›Paper›PMID 28081734›Full record

ArticleOncology research2017

MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells.

Kexin Lou, Ning Chen, Zhihong Li, Bei Zhang, Xiuli Wang, Ye Chen, Haining Xu, Dongwei Wang, Hao Wang

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Oncology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. LncRNA CKMT2-AS1 Promotes Hepatocellular Carcinoma Development Via Sponging miR-142-5p and Targeting IFITM3.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Non-Genomic Control of DynamicFrontiers in oncology · 2020
    Review
  19. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.International journal of molecular sciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kexin LouDepartment of Ultrasound, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Ning ChenDepartment of Gynecology and Obstetrics, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Zhihong LiDepartment of Ultrasound, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Bei ZhangDepartment of Gynecology and Obstetrics, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Xiuli WangCentral Laboratory, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Ye ChenDepartment of Ultrasound, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Haining XuDepartment of Ultrasound, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Dongwei WangDepartment of Ultrasound, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Hao WangDepartment of Ultrasound, Xuzhou Central HospitalXuzhou, JiangsuP.R. China.
Xuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormal expression of microRNA (miR)-142-5p has been reported in hepatocellular carcinoma (HCC). However, little information is available regarding the functional role of miR-142-5p in HCC. We aimed to explore the effects of miR-142-5p aberrant expression on HCC cell growth and cell apoptosis, as well as the underlying mechanism. Human HCC cell lines HepG2 and SMMC-7721 cells were transfected with miR-142-5p mimic, inhibitor, or a corresponding negative control. Cell viability, cell cycle distribution, and cell apoptosis were then analyzed. In addition, protein expression of Forkhead box, class O (FOXO) 1 and 3, a Bcl-2-interacting mediator of cell death (Bim), procaspase 3, and activated caspase 3 was measured. After transfection with miR-142-5p inhibitor, FOXO1 and FOXO3 were overexpressed, and then the cell viability and cell apoptosis were determined again. The relative cell viability in both HepG2 and SMMC-7721 cells was significantly reduced by miR-142-5p overexpression (p < 0.05). miR-142-5p overexpression displayed a significant blockage at the G1/S transition and significantly increased the percentages of G0/G1 phase. Moreover, the results showed that miR-142-5p overexpression significantly induced cell apoptosis and statistically elevated the protein expression levels of FOXO1, FOXO3, Bim, procaspase 3, and activated caspase 3. However, the cells transfected with miR-142-5p inhibitor showed contrary results. Additionally, the effects of miR-142-5p inhibitor on cell viability and apoptosis were reversed by overexpression of FOXO. In conclusion, our results suggest that miR-142-5p overexpression shows an important protective role in HCC by inhibiting cell growth and inducing apoptosis. These effects might be by regulating FOXO expression in HCC cells.

Indexed as

Gene Expression Regulation, NeoplasticApoptosisCarcinoma, HepatocellularCell Cycle CheckpointsCell Line, TumorCell MovementCell ProliferationCell SurvivalForkhead Box Protein O1HumansLiver NeoplasmsMicroRNAsForkhead Box Protein O1MicroRNAsMIRN142 microRNA, human

Identifiers

PMID28081734
PMCPMC7840786
OpenAlexW2573178309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.